Lord, Abbett & Co
EPZM

Lord, Abbett & Co’s Epizyme, Inc EPZM Stock Holding History

Lord, Abbett & Co’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-478,793
Closed -$8.5M – 916
2018
Q1 		$8.5M Sell
478,793
-260
-0.1% -$4.39K 0.03% 644
2017
Q4 		$6.01M Sell
479,053
-150,613
-24% -$2.19M 0.02% 723
2017
Q3 		$12M Sell
629,666
-14,415
-2% -$220K 0.04% 598
2017
Q2 		$9.73M Buy
+644,081
New +$9.74M 0.03% 637
2016
Q1 		– Sell
-78,041
Closed -$1.25M – 965
2015
Q4 		$1.25M Sell
78,041
-42,322
-35% -$627K ﹤0.01% 859
2015
Q3 		$1.55M Sell
120,363
-208,508
-63% -$4.21M ﹤0.01% 865
2015
Q2 		$7.89M Buy
328,871
+241,737
+277% +$4.65M 0.02% 679
2015
Q1 		$1.64M Sell
87,134
-23,980
-22% -$495K ﹤0.01% 871
2014
Q4 		$2.1M Sell
111,114
-655,851
-86% -$15.3M 0.01% 859
2014
Q3 		$20.8M Buy
766,965
+400,214
+109% +$12.4M 0.05% 479
2014
Q2 		$11.4M Buy
366,751
+260,315
+245% +$6.13M 0.03% 613
2014
Q1 		$2.42M Sell
106,436
-336
-0.3% -$10.2K 0.01% 909
2013
Q4 		$2.22M Sell
106,772
-2,048
-2% -$59.4K ﹤0.01% 977
2013
Q3 		$4.37M Buy
+108,820
New +$3.69M 0.01% 833

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Lord, Abbett & Co's EPZM Position: Q2 2018 in Review

Lord, Abbett & Co sold out of Epizyme, Inc (EPZM) in Q2 2018, closing a stake of 478,793 shares — an estimated $8.5M sold.

Lord, Abbett & Co first reported a position in EPZM in Q3 2013 and held it in 14 quarters. The position peaked at $20.8M in Q3 2014. 109 funds tracked by Wall St. Rank hold EPZM as of Q2 2018.

  • Lord, Abbett & Co reported no remaining Epizyme, Inc position as of Q2 2018 after selling out during the quarter.
  • Lord, Abbett & Co sold 478,793 Epizyme, Inc shares in Q2 2018, an estimated $8.5M.
  • Lord, Abbett & Co first reported a position in Epizyme, Inc in Q3 2013 and held it in 14 quarters.
  • Lord, Abbett & Co's Epizyme, Inc position peaked at $20.8M in Q3 2014.
  • 109 funds tracked by Wall St. Rank held Epizyme, Inc as of Q2 2018.

Based on Lord, Abbett & Co's 13F filing for Q2 2018, filed 14 Aug 2018.